Archives of Virology

, Volume 151, Issue 11, pp 2133–2148 | Cite as

Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes

  • Y.-F. Xu
  • Y.-Q. Zhang
  • X.-M. Xu
  • G.-X. Song
Article

Summary.

Papillomaviruses (PVs) are simple double-strand DNA viruses whose virion shells are T = 7 icosahedrons and composed of major capsid protein L1 and minor capsid protein L2.L1 alone or together with L2 can self-assemble into virus-like particles (VLPs) when expressed in eukaryotic or prokaryotic expression systems. Although the VLPs lack the virus genome DNA, their morphological and immunological characteristics are very similar to those of nature papillomaviruses. PV VLP vaccination can induce high titers of neutralizing antibodies and can effectively protect animals or humans from PV infection. Moreover, PV VLPs have been good candidates for vehicles to deliver epitopes or genes to target cells. They are widely used in the fields of vaccine development, neutralizing antibody detection, basic virologic research on papillomaviruses, and human papillomavirus (HPV) screening. Besides the structural biology and immunological basis for PV VLPs used as vehicles to deliver epitopes or genes, this review details the latest findings on chimeric papillomavirus VLPs and papillomavirus pseudoviruses, which are two important forms of PV VLPs used to transfer epitopes or genes.

Abbreviations

PV

Papillomavirus

VLPs

virus-like particles

cVLPs

chimeric virus-like particles

HPV

human papillomavirus

DCs

dendritic cells

LCs

Langerhans cells

IL

interleukin

TNF

tumor necrosis factor

INF

interferon

CTLs

cytotoxic T lymphocytes

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ault, KA, Giuliano, AR, Edwards, RP, Tamms, G, Kim, LL, Smith, JF, Jansen, KU, Allende, M, Taddeo, FJ, Skulsky, D, Barr, E 2004A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccineVaccine2230043007PubMedGoogle Scholar
  2. Baseman, JG, Koutsky, LA 2005The epidemiology of human papillomavirus infectionsJ Clin Virol32S16S24PubMedGoogle Scholar
  3. Bontkes, HJ, Ruizendaal, JJ, Kramer, D, Meijer, CJ, Hooijberg, E 2005Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particlesGynecol Oncol96897901PubMedGoogle Scholar
  4. Bousarghin, L, Combita-Rojas, AL, Touze, A, El Mehdaoui, S, Sizaret, PY, Bravo, MM, Coursaget, P 2002Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirionsJ Clin Microbiol40926932PubMedGoogle Scholar
  5. Breitburd, F, Kirnbauer, R, Hubbert, NL, Nonnenmacher, B, Trin-Dinh-Desmarquet, C, Orth, G, Schiller, JT, Lowy, DR 1995Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infectionJ Virol6939593963PubMedGoogle Scholar
  6. Brown, DR, Bryan, JT, Schroeder, JM, Robinson, TS, Fife, KH, Wheeler, CM, Barr, E, Smith, PR, Chiacchierini, L, DiCello, A, Jansen, KU 2001Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titerJ Infect Dis18411831186PubMedGoogle Scholar
  7. Brown, DR, Fife, KH, Wheeler, CM, Koutsky, LA, Lupinacci, LM, Railkar, R, Suhr, G, Barr, E, Dicello, A, Li, W, Smith, JF, Tadesse, A, Jansen, KU 2004Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccineVaccine2229362942PubMedGoogle Scholar
  8. Buck, CB, Pastrana, DV, Lowy, DR, Schiller, JT 2004Efficient intracellular assembly of papillomaviral vectorsJ Virol78751757PubMedGoogle Scholar
  9. Buck, CB, Thompson, CD, Pang, YY, Lowy, DR, Schiller, JT 2005Maturation of papillomavirus capsidsJ Virol7928392846PubMedGoogle Scholar
  10. Chackerian, B, Lowy, DR, Schiller, JT 1999Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particlesProc Natl Acad Sci USA9623732378PubMedGoogle Scholar
  11. Chackerian, B, Lowy, DR, Schiller, JT 2001Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodiesJ Clin Invest108415423PubMedGoogle Scholar
  12. Chackerian, B, Lenz, P, Lowy, DR, Schiller, JT 2002Determinants of autoantibody induction by conjugated papillomavirus virus-like particlesJ Immunol16961206126PubMedGoogle Scholar
  13. Chen, XS, Garcea, RL, Goldberg, I, Casini, G, Harrison, SC 2000Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16Mol Cell5557567PubMedGoogle Scholar
  14. Combita, AL, Touze, A, Bousarghin, L, Sizaret, PY, Munoz, N, Coursaget, P 2001Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfateFEMS Microbiol Lett204183188PubMedGoogle Scholar
  15. de Villiers, EM, Fauquet, C, Broker, TR, Bernard, HU, zur Hausen, H 2004Classification of papillomavirusesVirology3241727PubMedGoogle Scholar
  16. Da Silva, DM, Schiller, JT, Kast, WM 2003Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccinesVaccine2132193227PubMedGoogle Scholar
  17. Doorbar, J 2005The papillomavirus life cycleJ Clin Virol32S7S15PubMedGoogle Scholar
  18. Drobni, P, Mistry, N, McMillan, N, Evander, M 2003Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entryVirology310163172PubMedGoogle Scholar
  19. Emeny, RT, Wheeler, CM, Jansen, KU, Hunt, WC, Fu, TM, Smith, JF, MacMullen, S, Esser, MT, Paliard, X 2002Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccineJ Virol7678327842PubMedGoogle Scholar
  20. Evander, M, Frazer, IH, Payne, E, Qi, YM, Hengst, K, McMillan, NA 1997Identification of the alpha6 integrin as a candidate receptor for papillomavirusesJ Virol7124492456PubMedGoogle Scholar
  21. Evans, TG, Bonnez, W, Rose, RC, Koenig, S, Demeter, L, Suzich, JA, O’Brien, D, Campbell, M, White, WI, Balsley, J, Reichman, RC 2001A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteersJ Infect Dis18314851493PubMedGoogle Scholar
  22. Fausch, SC, Da Silva, DM, Rudolf, MP, Kast, WM 2002Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomavirusesJ Immunol16932423249PubMedGoogle Scholar
  23. Fausch, SC, Da Silva, DM, Kast, WM 2003Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cellsCancer Res6334783482PubMedGoogle Scholar
  24. Fausch, SC, Fahey, LM, Da Silva, DM, Kast, WM 2005Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activationJ Immunol17471727178PubMedGoogle Scholar
  25. Fausch, SC, Da Silva, DM, Kast, WM 2005Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cellsVaccine2317201729PubMedGoogle Scholar
  26. Fayad, R, Zhang, H, Quinn, D, Huang, Y, Qiao, L 2004Oral administration with papillomavirus pseudovirus encoding IL-2 fully restores mucosal and systemic immune responses to vaccinations in aged miceJ Immunol17326922698PubMedGoogle Scholar
  27. Fife, KH, Wheeler, CM, Koutsky, LA, Barr, E, Brown, DR, Schiff, MA, Kiviat, NB, Jansen, KU, Barber, H, Smith, JF, Tadesse, A, Giacoletti, K, Smith, PR, Suhr, G, Johnson, DA 2004Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy womenVaccine2229432952PubMedGoogle Scholar
  28. Frazer, IH 2004Prevention of cervical cancer through papillomavirus vaccinationNat Rev Immunol44654PubMedGoogle Scholar
  29. Freyschmidt, EJ, Alonso, A, Hartmann, G, Gissmann, L 2004Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitolAntivir Ther9479489PubMedGoogle Scholar
  30. Giroglou, T, Florin, L, Schafer, F, Streeck, RE, Sapp, M 2001Human papillomavirus infection requires cell surface heparan sulfateJ Virol7515651570PubMedGoogle Scholar
  31. Greenstone, HL, Nieland, JD, de Visser, KE, De Bruijn, ML, Kirnbauer, R, Roden, RB, Lowy, DR, Kast, WM, Schiller, JT 1998Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor modelProc Natl Acad Sci USA9518001805PubMedGoogle Scholar
  32. Harper, DM, Franco, EL, Wheeler, C, Ferris, DG, Jenkins, D, Schuind, A, Zahaf, T, Innis, B, Naud, P, De Carvalho, NS, Roteli-Martins, CM, Teixeira, J, Blatter, MM, Korn, AP, Quint, W, Dubin, G 2004Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialLancet36417571765PubMedGoogle Scholar
  33. Ionescu, RM, Przysiecki, CT, Liang, X, Garsky, VM, Fan, J, Wang, B, Troutman, R, Rippeon, Y, Flanagan, E, Shiver, J, Shi, L 2006Pharmaceutical and immunological evaluation of human papillomavirus virus like particle as an antigen carrierJ Pharm Sci957079PubMedGoogle Scholar
  34. Joyce, JG, Tung, JS, Przysiecki, CT, Cook, JC, Lehman, ED, Sands, JA, Jansen, KU, Keller, PM 1999The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytesJ Biol Chem27458105822PubMedGoogle Scholar
  35. Kang, SM, Yao, Q, Guo, L, Compans, RW 2003Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit BJ Virol7798239830PubMedGoogle Scholar
  36. Kawana, K, Yoshikawa, H, Taketani, Y, Yoshiike, K, Kanda, T 1998In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsidsJ Virol721029810300PubMedGoogle Scholar
  37. Kirnbauer, R, Booy, F, Cheng, N, Lowy, DR, Schiller, JT 1992Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenicProc Natl Acad Sci USA891218012184PubMedGoogle Scholar
  38. Kirnbauer, R, Taub, J, Greenstone, H, Roden, R, Durst, M, Gissmann, L, Lowy, DR, Schiller, JT 1993Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particlesJ Virol6769296936PubMedGoogle Scholar
  39. Klagge, IM, Schneider-Schaulies, S 1999Virus interactions with dendritic cellsJ Gen Virol80823833PubMedGoogle Scholar
  40. Koutsky, LA, Ault, KA, Wheeler, CM, Brown, DR, Barr, E, Alvarez, FB, Chiacchierini, LM, Jansen, KU 2002A controlled trial of a human papillomavirus type 16 vaccineN Engl J Med34716451651PubMedGoogle Scholar
  41. Kowalczyk, DW, Wlazlo, AP, Shane, S, Ertl, HC 2001Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16Vaccine1935833590PubMedGoogle Scholar
  42. Lenz, P, Day, PM, Pang, YY, Frye, SA, Jensen, PN, Lowy, DR, Schiller, JT 2001Papillomavirus-like particles induce acute activation of dendritic cellsJ Immunol16653465355PubMedGoogle Scholar
  43. Lenz, P, Lowy, DR, Schiller, JT 2005Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cellsEur J Immunol3515481556PubMedGoogle Scholar
  44. Liu, WJ, Gissmann, L, Sun, XY, Kanjanahaluethai, A, Muller, M, Doorbar, J, Zhou, J 1997Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virionsVirology227474483PubMedGoogle Scholar
  45. Liu, WJ, Liu, XS, Zhao, KN, Leggatt, GR, Frazer, IH 2000Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopesVirology273374382PubMedGoogle Scholar
  46. Liu, Y, Frazer, IH, Liu, WJ, Liu, XS, McMillan, N, Zhao, KN 2001Efficiency of delivery of DNA to cells by bovine papillomavirus type-1 L1/L2 pseudovirionsAppl Microbiol Biotechnol56150156PubMedGoogle Scholar
  47. Ludmerer, SW, Benincasa, D, Mark, GE,III 1996Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11J Virol7047914794PubMedGoogle Scholar
  48. Ludmerer, SW, Benincasa, D, Mark, GE,III, Christensen, ND 1997A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitopeJ Virol7138343839PubMedGoogle Scholar
  49. Ludmerer, SW, McClements, WL, Wang, XM, Ling, JC, Jansen, KU, Christensen, ND 2000HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domainVirology266237245PubMedGoogle Scholar
  50. McClements, WL, Wang, XM, Ling, JC, Skulsky, DM, Christensen, ND, Jansen, KU, Ludmerer, SW 2001A novel human papillomavirus type 6 neutralizing domain comprising two discrete regions of the major capsid protein L1Virology289262268PubMedGoogle Scholar
  51. Muller, M, Gissmann, L, Cristiano, RJ, Sun, XY, Frazer, IH, Jenson, AB, Alonso, A, Zentgraf, H, Zhou, J 1995Papillomavirus capsid binding and uptake by cells from different tissues and speciesJ Virol69948954PubMedGoogle Scholar
  52. Muller, M, Zhou, J, Reed, TD, Rittmuller, C, Burger, A, Gabelsberger, J, Braspenning, J, Gissmann, L 1997Chimeric papillomavirus-like particlesVirology23493111PubMedGoogle Scholar
  53. Munoz, N, Bosch, FX, de Sanjose, S, Herrero, R, Castellsague, X, Shah, KV, Snijders, PJ, Meijer, CJ 2003Epidemiologic classification of human papillomavirus types associated with cervical cancerN Engl J Med348518527PubMedGoogle Scholar
  54. Nardelli-Haefliger, D, Lurati, F, Wirthner, D, Spertini, F, Schiller, JT, Lowy, DR, Ponci, F, De Grandi, P 2005Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccineVaccine2336343641PubMedGoogle Scholar
  55. Nieland, JD, Da Silva, DM, Velders, MP, de Visser, KE, Schiller, JT, Muller, M, Kast, WM 1999Chimeric papillomavirus virus-like particles induce a murine self-antigen-specific protective and therapeutic antitumor immune responseJ Cell Biochem73145152PubMedGoogle Scholar
  56. Oh, YK, Sohn, T, Park, JS, Kang, MJ, Choi, HG, Kim, JA, Kim, WK, Ko, JJ, Kim, CK 2004Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvantVirology328266273PubMedGoogle Scholar
  57. Orozco, JJ, Carter, JJ, Koutsky, LA, Galloway, DA 2005Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomersJ Virol7995039514PubMedGoogle Scholar
  58. Pagliusi, SR, Teresa, AM 2004Efficacy and other milestones for human papillomavirus vaccine introductionVaccine23569578PubMedGoogle Scholar
  59. Paintsil, J, Muller, M, Picken, M, Gissmann, L, Zhou, J 1996Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formationVirology223238244PubMedGoogle Scholar
  60. Pastrana, DV, Vass, WC, Lowy, DR, Schiller, JT 2001NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16Virology279361369PubMedGoogle Scholar
  61. Pastrana, DV, Buck, CB, Pang, YY, Thompson, CD, Castle, PE, FitzGerald, PC, Kruger, KS, Lowy, DR, Schiller, JT 2004Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18Virology321205216PubMedGoogle Scholar
  62. Peng, S, Frazer, IH, Fernando, GJ, Zhou, J 1998Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathwayVirology240147157PubMedGoogle Scholar
  63. Pinto, AP, Baggio, HC, Guedes, GB 2005Sexually-transmitted viral diseases in women: clinical and epidemiological aspects and advances in laboratory diagnosisBraz J Infect Dis9241250PubMedGoogle Scholar
  64. Pinto, LA, Edwards, J, Castle, PE, Harro, CD, Lowy, DR, Schiller, JT, Wallace, D, Kopp, W, Adelsberger, JW, Baseler, MW, Berzofsky, JA, Hildesheim, A 2003Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particlesJ Infect Dis188327338PubMedGoogle Scholar
  65. Pinto, LA, Castle, PE, Roden, RB, Harro, CD, Lowy, DR, Schiller, JT, Wallace, D, Williams, M, Kopp, W, Frazer, IH, Berzofsky, JA, Hildesheim, A 2005HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole bloodVaccine2335553564PubMedGoogle Scholar
  66. Reis e Sousa, , Sher, A, Kaye, P 1999The role of dendritic cells in the induction and regulation of immunity to microbial infectionCurr Opin Immunol11392399PubMedGoogle Scholar
  67. Roden, RB, Greenstone, HL, Kirnbauer, R, Booy, FP, Jessie, J, Lowy, DR, Schiller, JT 1996In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotypeJ Virol7058755883PubMedGoogle Scholar
  68. Rommel, O, Dillner, J, Fligge, C, Bergsdorf, C, Wang, X, Selinka, HC, Sapp, M 2005Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISAJ Med Virol75114121PubMedGoogle Scholar
  69. Rossi, JL, Gissmann, L, Jansen, K, Muller, M 2000Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiaeHum Gene Ther1111651176PubMedGoogle Scholar
  70. Rudolf, MP, Fausch, SC, Da Silva, DM, Kast, WM 2001Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitroJ Immunol16659175924PubMedGoogle Scholar
  71. Ruiz, W, McClements, WL, Jansen, KU, Esser, MT 2005Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvantJ Immune Based Ther Vaccines32PubMedGoogle Scholar
  72. Sadeyen, JR, Tourne, S, Shkreli, M, Sizaret, PY, Coursaget, P 2003Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitopeVirology3093240PubMedGoogle Scholar
  73. Sapp, M, Selinka, HC 2005Pseudovirions as specific tools for investigation of virus interactions with cellsMethods Mol Biol292197212PubMedGoogle Scholar
  74. Schafer, K, Muller, M, Faath, S, Henn, A, Osen, W, Zentgraf, H, Benner, A, Gissmann, L, Jochmus, I 1999Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protectionInt J Cancer81881888PubMedGoogle Scholar
  75. Shi, W, Liu, J, Huang, Y, Qiao, L 2001Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responsesJ Virol751013910148PubMedGoogle Scholar
  76. Slupetzky, K, Shafti-Keramat, S, Lenz, P, Brandt, S, Grassauer, A, Sara, M, Kirnbauer, R 2001Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loopsJ Gen Virol8227992804PubMedGoogle Scholar
  77. Stauffer, Y, Raj, K, Masternak, K, Beard, P 1998Infectious human papillomavirus type 18 pseudovirionsJ Mol Biol283529536PubMedGoogle Scholar
  78. Storni, T, Ruedl, C, Schwarz, K, Schwendener, RA, Renner, WA, Bachmann, MF 2004Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effectsJ Immunol17217771785PubMedGoogle Scholar
  79. Suzich, JA, Ghim, SJ, Palmer-Hill, FJ, White, WI, Tamura, JK, Bell, JA, Newsome, JA, Jenson, AB, Schlegel, R 1995Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomasProc Natl Acad Sci USA921155311557PubMedGoogle Scholar
  80. Tan, TM, Ting, RC 1995In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genesCancer Res5545994605PubMedGoogle Scholar
  81. Tobery, TW, Smith, JF, Kuklin, N, Skulsky, D, Ackerson, C, Huang, L, Chen, L, Cook, JC, McClements, WL, Jansen, KU 2003Effect of vaccine delivery system on the induction of HPV16L1-specific humoral and cell-mediated immune responses in immunized rhesus macaquesVaccine2115391547PubMedGoogle Scholar
  82. Touze, A, Coursaget, P 1998In vitro gene transfer using human papillomavirus-like particlesNucleic Acids Res2613171323PubMedGoogle Scholar
  83. Trus, BL, Roden, RB, Greenstone, HL, Vrhel, M, Schiller, JT, Booy, FP 1997Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolutionNat Struct Biol4413420PubMedGoogle Scholar
  84. Unckell, F, Streeck, RE, Sapp, M 1997Generation and neutralization of pseudovirions of human papillomavirus type 33J Virol7129342939PubMedGoogle Scholar
  85. von Knebel, DM, Rittmuller, C, zur Hausen, H, Durst, M 1992Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6–E7 anti-sense RNAInt J Cancer51831834Google Scholar
  86. Varsani, A, Williamson, AL, de Villiers, D, Becker, I, Christensen, ND, Rybicki, EP 2003Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16J Virol7783868393PubMedGoogle Scholar
  87. Villa, LL, Costa, RL, Petta, CA, Andrade, RP, Ault, KA, Giuliano, AR, Wheeler, CM, Koutsky, LA, Malm, C, Lehtinen, M, Skjeldestad, FE, Olsson, SE, Steinwall, M, Brown, DR, Kurman, RJ, Ronnett, BM, Stoler, MH, Ferenczy, A, Harper, DM, Tamms, GM, Yu, J, Lupinacci, L, Railkar, R, Taddeo, FJ, Jansen, KU, Esser, MT, Sings, HL, Saah, AJ, Barr, E 2005Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLancet Oncol6271278PubMedGoogle Scholar
  88. Volpers, C, Unckell, F, Schirmacher, P, Streeck, RE, Sapp, M 1995Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cellsJ Virol6932583264PubMedGoogle Scholar
  89. Wakabayashi, MT, Da Silva, DM, Potkul, RK, Kast, WM 2002Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor preventionIntervirology45300307PubMedGoogle Scholar
  90. Yan, M, Peng, J, Jabbar, IA, Liu, X, Filgueira, L, Frazer, IH, Thomas, R 2004Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cellsVirology324297310PubMedGoogle Scholar
  91. Yan, M, Peng, J, Jabbar, IA, Liu, X, Filgueira, L, Frazer, IH, Thomas, R 2005Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-kappaB-mediated signalling, moderated by TGF-betaImmunol Cell Biol838391PubMedGoogle Scholar
  92. Yang, R, Murillo, FM, Cui, H, Blosser, R, Uematsu, S, Takeda, K, Akira, S, Viscidi, RP, Roden, RB 2004Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88J Virol781115211160PubMedGoogle Scholar
  93. Yang, R, Murillo, FM, Lin, KY, Yutzy, WH, Uematsu, S, Takeda, K, Akira, S, Viscidi, RP, Roden, RB 2004Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulationsJ Immunol17326242631PubMedGoogle Scholar
  94. Yoon, CS, Kim, KD, Park, SN, Cheong, SW 2001alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLPBiochem Biophys Res Commun283668673PubMedGoogle Scholar
  95. zur Hausen, H, de Villiers, EM, Gissmann, L 1981Papillomavirus infections and human genital cancerGynecol Oncol12S124S128PubMedGoogle Scholar
  96. zur Hausen, H 2002Papillomaviruses and cancer: from basic studies to clinical applicationNat Rev Cancer2342350PubMedGoogle Scholar
  97. Zhang, H, Fayad, R, Wang, X, Quinn, D, Qiao, L 2004Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gagJ Virol781024910257PubMedGoogle Scholar
  98. Zhang, H, Huang, Y, Fayad, R, Spear, GT, Qiao, L 2004Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particlesJ Virol7883428348PubMedGoogle Scholar
  99. Zhang, LF, Zhou, J, Chen, S, Cai, LL, Bao, QY, Zheng, FY, Lu, JQ, Padmanabha, J, Hengst, K, Malcolm, K, Frazer, IH 2000HPV6b virus like particles are potent immunogens without adjuvant in manVaccine1810511058PubMedGoogle Scholar
  100. Zhao, KN, Sun, XY, Frazer, IH, Zhou, J 1998DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1Virology243482491PubMedGoogle Scholar
  101. Zhao, KN, Hengst, K, Liu, WJ, Liu, YH, Liu, XS, McMillan, NA, Frazer, IH 2000BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirionsVirology272382393PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Y.-F. Xu
    • 1
  • Y.-Q. Zhang
    • 2
  • X.-M. Xu
    • 1
  • G.-X. Song
    • 1
  1. 1.Department of Biophysics and Structural Biology Institute of Basic Medical SciencesChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingP.R. China
  2. 2.Department of Physical EducationZhejiang Water Conservancy and Hydropower CollegeHangzhouP.R. China

Personalised recommendations